EBM Sept 2020 Flashcards

1
Q

What type of fractures are patients on bisphosphonates at risk for?

A

Atypical Fractures increase with duration
Asians > Whites
Risk of atypical fractures are less than that of osteoporotic fractures

Black DM, Geiger EJ, Eastell R, et al. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020 Aug 20;383(8):743-753. doi: 10.1056/NEJMoa1916525.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the USPSTF recommendation for counseling to reduce STI? (2020)

A

2020 Statement: The USPSTF concludes with moderate certainty that behavioral counseling interventions reduce the likelihood of acquiring STIs in sexually active adolescents and in adults at increased risk, including for example, those who have a current STI, do not use condoms, or have multiple partners, resulting in a moderate net benefit.

Krist AH, Davidson KW, Mangione CM, et al. Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Aug 18;324(7):674-681. doi: 10.1001/jama.2020.13095.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Do SGLT-2 inhibitors lead to below the knee amputations?

A

Overall, the studies are inconsistent
However, per this study, no
- 11 months prospective observational study
- 200k SGLT2 vs 200k DPP4i patients

Positives: Prospective, large comparison
Negatives: Short follow up

Yu OHY, Dell`Aniello S, Shah BR, et al. Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study. Diabetes Care. 2020 Aug 5. pii: dc20-0267. doi: 10.2337/dc20-0267.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Do PAPR (Powered Air Purifying Respirators) more protective in regards to contracting respiratory illnesses compared to other respiratory equipment?

A

Low quality evidence
Doesn’t appear to be

Licina A, Silvers A, Stuart RL Use of powered air-purifying respirator (PAPR) by healthcare workers for preventing highly infectious viral diseases-a systematic review of evidence. Syst Rev. 2020 Aug 8;9(1):173. doi: 10.1186/s13643-020-01431-5.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Does endovascular therapy for (IACS) intracranial atherosclerotic stenosis in symptomatic stroke prevent recurrent strokes compared to conventional medical therapy (e.g. anti platelets)?

A

No

Showed increased risk for stroke or death, ipsilateral stroke, ischemic stroke and hemorrhagic stroke in 30 days and 1 year

Con: high risk of bias, 600 people, 3 studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the relationship between neurosyphilis in primary, secondary and tertiary syphilis?

A

Neurosyphilis can occur in any of the stages, that is, it can occur in primary, secondary or tertiary syphilis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the most common presentation of ocular syphilis?

A

Panuveitis with loss of vision acuity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the options to induce remission in moderate to severe ulcerative colitis?

A

According to AGA guidelines 2019:

– steroids
– TNF alpha inhibitors: infliximab, golimumab, adalimumab 
- Integrated inhibitor: vedolizumab
- JAK inhibitor: tofacitinib
- IL 12/23 inhibitor: Ustekinumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rarely is there a condition that requires annual colonoscopy screening for colon cancer.

In what situation for ulcerative colitis does a patient require yearly colonoscopy screenings for colon cancer?

A

UC plus PSC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In general, following the diagnosis of ulcerative colitis, when should a patient receive his or her first colonoscopy for colon cancer screening?

A

Eight years after diagnosis

AGA guidelines 2019

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What type of infections are patients at risk for when taking Baricitinib?

A

Herpes Zoster

-Review: JAK kinase inhibitor

Winthrop KL, Harigai M, Genovese MC, et al. Infections in baricitinib clinical trials for patients with active rheumatoid arthritis. Ann Rheum Dis. 2020 Aug 11. pii: annrheumdis-2019-216852. doi: 10.1136/annrheumdis-2019-216852.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the first choice for inducing remission in patients with mild to moderate Ulcerative Colitis?

A

Oral 5 aminosalicylic acid (addition of 5-ASA enema with extensive left sided colitis)

Murray A, Nguyen TM, Parker CE, et al. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020 Aug 12;8:CD000543. doi: 10.1002/14651858.CD000543.pub5.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of diabetic patients will benefit from intensive glucose control to decrease the development of MACE (Major Adverse Cardiovascular Events)?

A

Patients with short duration of diabetes, no previous cardiovascular events and long life expectency - AKA newly diagnosed diabetes w/o complications

Review: Generally, intensive glucose control has only demonstrated to decrease microvascular complications - Not macro

Prattichizzo F, de Candia P, De Nigris V, et al. Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios. Metabolism. 2020 Sep;110:154308. doi: 10.1016/j.metabol.2020.154308. Epub 2020 Jul 4.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does genotype testing patients with ACS who receive PCI for CYP2C19*2 or *3 loss-of-function (LOF) variants and then prescribing them the appropriate P2Y12 inhibitor (Clopidogrel vs Ticagrelor) reduce cardiac events?

A

TAILOR-PCI Trial

No difference between the two groups

The primary end point was a composite of cardiovascular death, myocardial infarction, stroke, stent thrombosis, and severe recurrent ischemia at 12 months.

Pereira NL, Farkouh ME, So D, et al. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial. JAMA. 2020 Aug 25;324(8):761-771. doi: 10.1001/jama.2020.12443.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Does supplementing Vitamin D deficient Asthma patients with Vit D3 reduce severe asthma exacerbations?

A

No

Double blind RCT
90 patients vs 90 patients

Forno E, Bacharier LB, Phipatanakul W, et al. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial. JAMA. 2020 Aug 25;324(8):752-760. doi: 10.1001/jama.2020.12384.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does Metformin compare to OCP in treating hirsuitism in PCOS?

A

Cochrane review
Low to very low quality evidence

Cautious conclusion: In adult women with PCOS, metformin may be less effective in improving hirsutism compared to the OCP in the subgroup BMI 25 kg/m2 to 30 kg/m2 but we are uncertain if there was a difference between metformin and the OCP in subgroups BMI < 25 kg/m2 and BMI > 30kg/m2.

Either metformin alone or the OCP alone may be less effective in improving hirsutism compared to metformin combined with the OCP.

Fraison E, Kostova E, Moran LJ, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev. 2020 Aug 13;8:CD005552. doi: 10.1002/14651858.CD005552.pub3.

17
Q

Patient has PAD and Type II DM. He continues to be uncontrolled on his Type II DM. You’d like to start Dapagloflozin, but patient asks you about the risk of amputation especially since he already has PAD. What is your response?

A
  • Patients with PAD are at higher risks of MACE compared to patients without PAD at baseline
  • Patients with PAD are at higher risk of amputation vs patients without PAD at baseline
  • Dapagloflozin doesn’t add any incremental risk of amputation, but does decrease the progression of renal disease and hospitalization 2/2 HF/CV death

Bonaca MP, Wiviott SD, Zelniker TA, et al. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58. Circulation. 2020 Aug 25;142(8):734-747. doi: 10.1161/CIRCULATIONAHA.119.044775. Epub 2020 Aug 3.

18
Q

What is the preferred P2Y12 inhibitor following ACS with PCI?

A

Prasugrel or Ticagrelor > Clopidogrel

19
Q

Is there a difference between Prasugrel vs Ticagrelor for ACS followed by PCI in regards to MACCE?

TIP: MACE - major adverse cardiovascular events; MACCE - major adverse cardiovascular and cerebrovascular events

A

No
Meta-analysis
27 studies - 7 RCTs and 20 Observational
Subgroup analysis of RCT showed now difference of MACCE at 30 days or 1 year.

Ullah W, Ali Z, Sadiq U, et al. Meta-Analysis Comparing the Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome. Am J Cardiol. 2020 Jul 17. pii: S0002-9149(20)30688-3. doi: 10.1016/j.amjcard.2020.07.017.

20
Q

Does eating a diet low in saturated fats lead to less cardiovascular events?

A

Cochrane review

  • The included long-term trials suggested that reducing dietary saturated fat reduced the risk of combined cardiovascular event, GRADE moderate-quality evidence.
  • little or no effect of reducing saturated fat on all-cause mortality or cardiovascular mortality, both with GRADE moderate-quality evidence.
  • The number needed to treat for an additional beneficial outcome (NNTB) was 56 in primary prevention trials, so 56 people need to reduce their saturated fat intake for ~four years for one person to avoid experiencing a CVD event. In secondary prevention trials, the NNTB was 53.

Hooper L, Martin N, Jimoh OF, et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020 Aug 21;8:CD011737. doi: 10.1002/14651858.CD011737.pub3

21
Q

How does Edoxaban compare to VKA in regards to bleeding risk?

A

Meta-analysis

Edoxaban was associated with reduced risks of major or clinically relevant nonmajor bleeding (CRNM) events, any bleeding events, and intracranial bleeding events. They had a similar risk of gastro-intestinal bleeding, death from any cause, stroke and systemic embolic events between edoxaban and VKAs

Chen HB, Xiu J, Li YH, et al. The risk of bleeding and all-cause mortality with edoxaban versus vitamin K antagonists: A meta-analysis of phase III randomized controlled trials. Thromb Res. 2020 Jun 15

22
Q

What was the ODYSSEY study?

A

Compared placebo with alirocumab in patients with recent ACS

  • Alirocumab reduced risk of the primary outcome (coronary heart disease death, non-fatal myocardial infarction, ischaemic stroke, or unstable angina requiring hospitalization) with fewer deaths
23
Q

Does Alirocumab provide more reduction in cardiovascular outcomes depending on the GFR?

A

In patients with recent ACS, alirocumab was associated with fewer cardiovascular events and deaths across the range of renal function studied, with larger relative risk reductions in those with eGFR > 60 mL/min/1.73 m2

Tunon J, Steg PG, Bhatt DL, et al. Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial. Eur Heart J. 2020 Aug 21. pii: 5895197. doi: 10.1093/eurheartj/ehaa49

24
Q

Does colchicine reduce cardiovascular events in patients with chronic CAD?

A

YES

  • Double blind RCT
  • 2700 vs 2700
  • A primary end-point event occurred in 187 patients (6.8%) in the colchicine group and in 264 patients (9.6%) in the placebo group (incidence, 2.5 vs. 3.6 events per 100 person-years; hazard ratio, 0.69; 95% confidence interval [CI], 0.57 to 0.83; P<0.001
    Primary end point: composite of cardiovascular death, spontaneous (nonprocedural) myocardial infarction, ischemic stroke, or ischemia-driven coronary revascularization

Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020 Aug 31. doi: 10.1056/NEJMoa2021372.

25
Q

What diabetic medication can be used for patients with heart failure to reduce cardiovascular events (EVEN if they DO NOT have diabetes?

A

SGLT-2

Empaglaflozin (EMPORER REDUCED TRIAL)
Canaglaflozin
Dapaglafozin (not significant results in study)

26
Q

What have studies demonstrated about early feeding in pediatric pancreatitis?

A

RCT
33 patients total
Primary outcome: time to discharge

There was no difference between early commencement of a standard oral diet and initial fast in any of the major outcome measures.

Ledder O, Duvoisin G, Lekar M, et al. Early Feeding in Acute Pancreatitis in Children: A Randomized Controlled Trial. Pediatrics. 2020 Aug 12. pii: peds.2020-1149. doi: 10.1542/peds.2020-1149.

27
Q

What is the benefit from therapeutic hypothermia after cardiac arrest?

A

Improved neurologic outcome
No change in mortality

Meta-analysis 2020

Rout A, Singh S, Sarkar S, et al. Meta-Analysis of the Usefulness of Therapeutic Hypothermia After Cardiac Arrest. Am J Cardiol. 2020 Jul 24. pii: S0002-9149(20)30772-4. doi: 10.1016/j.amjcard.2020.07.038

28
Q

What is the role of FDG PET scan in cancer screening for patients following unprovoked VTE?

A

Meta-analysis

Pooled sensitivity 87.3% (95% CI, 55.3 to 97.4)
Specificity 70.2% (95% CI, 48.2 to 85.6)
NPV 98.9% (95% CI, 94.3 to 99.7)
PPV 17.9% (95% CI, 8.5 to 33.6)

In particular, it exhibits a very high negative predictive value and could be used to rule out the presence of an underlying occult malignancy in this setting.

Robin P, van Es N, Le Roux PY, et al. Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. Thromb Res. 2020 Jun 23;194:153-157. doi: 10.1016/j.thromres.2020.06.034.